Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT00701623

Withdrawn

Sodic Heparin Effectiveness of the Treatment of Burns (Heparin)

Burns
NCT00680628

Terminated

Clot Dissolving Treatment for Blood Clots in the Lungs

Pulmonary Embolism
NCT01869413

Completed

Tranexamic Acid During Cystectomy Trial (TACT) (TACT)

Bladder Cancer
NCT04420299

Terminated

Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19

Covid-19
NCT02432547

Completed

Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO) (LADAMO)

Diabetic Retinopathy
NCT01433965

Completed

Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Acute Myeloid Leukemia | Myelodysplastic Syndrome
NCT05236569

Completed

Effectiveness and Safety of Intradermal Tranexamic Acid Injection as An Adjunctive Treatment for Melasma in Skin Type IV - V

Melasma
NCT01775644

Completed

An Observational Study of Avastin in Participants With Metastatic Colorectal Cancer (KORALLE)

Colorectal Cancer
NCT02859441

Completed

A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab

Von Hippel-Lindau Syndrome
NCT04970251

Completed

Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma

Intraocular Pressure | Neovascular Glaucoma | Vascular Endothelial Growth Factor Overexpression | Glaucoma Secondary to Eye Inflammation
NCT02112175

Completed

Lenalidomide vs Placebo Maintenance Therapy Following Melphalan Prednisone Velcade® Induction Therapy in NDMM (ARUMM)

Multiple Myeloma
NCT02232802

Completed

Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.

Enoxaparin Sodium is Administered to Healthy Volunteers
NCT04400916

Unknown

Topical Tranexamic Acid After Intravitreal Injections

Subconjunctival Hemorrhage
NCT00669578

Completed

CC-4047 in Treating Patients With Myelofibrosis

Chronic Myeloproliferative Disorders | Secondary Myelofibrosis
NCT03099031

Completed

Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE) (PREDICARE)

Venous Thromboembolism
NCT00717522

Terminated

Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma

Soft Tissue Sarcoma
NCT01324947

Completed

Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma

Multiple Myeloma
NCT00179608

Completed

Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy

Malignant Melanoma
NCT01397695

Completed

Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

Hereditary Hemorrhagic Telangiectasia (HHT)
NCT02744833

Terminated

Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)

Deep Venous Thrombosis
NCT01027468

Completed

Long-term Results After Intravitreal Bevacizumab Treatment Of Neovascular Age-related Macular Degeneration

Neovascular Age-related Macular Degeneration
NCT02970916

Completed

Phase II Trial to Assess FOLFIRI+Aflibercept Efficacy in Patients With Oxaliplatin-pretreated Metastatic Colorectal Cancer With or Without ACE Polymorphisms (POLAF)

Metastatic Colorectal Cancer
NCT03805672

Terminated

Below Knee DVT Study

Deep Vein Thrombosis (DVT) | Blood Clots
NCT03744806

Completed

Blood-aqueous Barrier Integrity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular AMD

Exudative Age-related Macular Degeneration
NCT01525290

Completed

Efficacy and Safety of MRI-based Thrombolysis in Wake-up Stroke (WAKE-UP)

Stroke
NCT01712347

Completed

An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal Cancer

Colorectal Cancer
NCT02321241

Completed

Real Life of Aflibercept in France in Patients Refractory to Ranibizumab: Observational Study in Wet AMD (TITAN)

Wet Macular Degeneration
NCT00866723

Terminated

Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Serous Cancer
NCT01766583

Completed

A Phase IB Study Of The BTKi CC-292 Combined With Lenalidomide In Adults Patients With Relapsed/Refractory B-Cell Lymphoma (CLEAR)

Relapsed/Refractory B-cell Lymphoma
NCT02233101

Completed

Oral vs. Intravenous TXA Study Proposal: TJA

Blood Loss After Primary Total Joint Arthroplasty | Need for Blood Transfusion After Total Joint Arthroplasty
NCT01494805

Completed

Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration (AMD)

Eye Diseases | Macular Degeneration | Retinal Degeneration | Retinal Neovascularization | Age-related Maculopathies | Age-related Maculopathy | Maculopathies,Age-related | Maculopathy,Age-related
NCT02496286

Terminated

Feasibility Study of Intraperitoneal Bevacizumab for Palliation of Intractable Malignant Ascites

Malignant Ascites
NCT03208335

Unknown

Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC)

Hepatocellular Carcinoma
NCT00931489

Completed

Retinal and Retinal Pigment Epithelium (RPE) Autoimmunity in Age-related Macular Degeneration (AMD) (Antibody)

Age Related Macular Degeneration
NCT00473330

Completed

A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE) (RISE)

Diabetes Mellitus | Macular Edema
NCT03008655

Unknown

1064-nm Q-switched Nd:YAG Laser and Intradermal Tranexamic Acid for Melasma

Melasma
NCT00744718

Completed

Bevacizumab and Carboplatin for Patients With Ovarian Cancer

Ovarian Cancer
NCT02810808

Unknown

Safety and Efficacy of Two Regimens of Ranibizumab 0.5 mg in Chinese Patients With Neovascular AMD (ARTIS)

Neovascular Age-related Macular Degeneration
NCT01139723

Completed

A Study of the Safety and Pharmacokinetics of MINT1526A, Administered Intravenously As a Single Agent and in Combination With Bevacizumab to Patients With Advanced Solid Tumors

Solid Cancers
NCT02653261

Completed

Safety and Efficacy of Intravenous Tranexamic Acid in Endoscopic Transurethral Resections in Urology

Hemorrhage
NCT01718899

Completed

Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma

Smoldering Multiple Myeloma
NCT01390051

Completed

Can Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight? (IUGR)

Fetal Growth Retardation
NCT01703364

Completed

Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLL

Chronic Lymphocytic Leukemia | CLL
NCT01950741

Completed

Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy (VAULT)

Polypoidal Choroidal Vasculopathy | Exudative Age-related Macular Degeneration
NCT02745561

Unknown

Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients.

Esophageal Cancer | Endostatin
NCT00000468

Completed

Myocardial Infarction Triage and Intervention Project (MITI)

Myocardial Infarction | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease
NCT01940692

Completed

Topical and Intravenous Administration of TXA Are Equally Effective in DAA THA

Osteoarthrosis
NCT02217956

Completed

Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma (CHIPASTIN)

Fallopian Tube Adenocarcinoma | Ovarian Adenocarcinoma | Primary Peritoneal Carcinoma
NCT02645552

Unknown

Pre-hospital Administration of Tranexamic Acid for Moderate and Severe Traumatic Brain Injury

Brain Injuries, Traumatic
NCT00515684

Withdrawn

Corneal Thinning During Topical Bevacizumab Therapy

Corneal Neovascularization

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations